Funding for this research was provided by:
International Transplant Nurses Society
Schweizerische Akademie der Medizinischen Wissenschaften
International Society for Heart and Lung Transplantation
Astellas Pharma US
European Union Regional Development Funds
Received: 8 February 2019
Accepted: 14 February 2020
First Online: 3 March 2020
Ethics approval and consent to participate
: Ethical approval is obtained from each participating centers’ IRB/ethics committee prior to data collection (e.g.: Ethische commissie UZ / KU Leuven, Number: B322201213667). The patient information and informed consent forms comply with the guidelines of the Declaration of Helsinki (World Medical Organization 1996) and specific national legislation (e.g. consideration of Health Insurance Portability and Accountability Act in the USA). All patients are informed in writing and orally about the aims of the study, why they are selected, what their involvement means in terms of data collection, the risks/benefits of taking part and who the contact persons are for the study. They are also informed that they have the right to discontinue their participation at any time without affecting their treatment by the transplant team or hospital. Safeguards to ensure patient confidentiality are explained and written informed consent is obtained from each patient prior to data collection.
: Not Applicable.
: The authors declare that they have no competing interests